Stem cell mystery: why some liver patients Don't get better
NCT ID NCT07198854
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study reviews medical records of 446 people with hepatitis B-related liver failure who received stem cell therapy. Researchers want to find out why some patients did not improve. The goal is to identify factors that affect treatment success so future patients can benefit more.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE-ON-CHRONIC LIVER FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Third Affiliated Hospital of Sun Yat-sen University
RECRUITINGGuangzhou, Guangdong, 510630, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental injection aims to combat Life-Threatening liver failure
- Blood transfusion strategy could be refined for liver patients
- Could stem cells offer a lifeline for sudden liver failure?
- New device aims to filter toxins in liver crisis
- New device aims to filter toxic iron from blood in liver failure patients
- New blood test could save lives in liver failure bleeding emergencies